scispace - formally typeset
Journal ArticleDOI

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor.

TLDR
Continuous intracerebral infusion of NGF over a period of four weeks can partly reverse the cholinergic cell body atrophy and improve retention of a spatial memory task in behaviourally impaired aged rats.
Abstract
In aged rodents, impairments in learning and memory have been associated with an age-dependent decline in forebrain of cholinergic function, and recent evidence indicates that the cholinergic neurons in the nucleus basalis magnocellularis, the septal-diagonal band area and the striatum undergo age-dependent atrophy. Thus, as in Alzheimer-type dementia in man, degenerative changes in the forebrain cholinergic system may contribute to age-related cognitive impairments in rodents. The cause of these degenerative changes is not known. Recent studies have shown that the central cholinergic neurons in the septal-diagonal band area, nucleus basalis and striatum are sensitive to the neurotrophic protein nerve growth factor (NGF). In particular, intraventricular injections or infusions of NGF in young adult rats have been shown to prevent retrograde neuronal cell death and promote behavioural recovery after damage to the septo-hippocampal connections. It is so far not known, however, whether the atrophic cholinergic neurons in aged animals are responsive to NGF treatment. We report here that continuous intracerebral infusion of NGF over a period of four weeks can partly reverse the cholinergic cell body atrophy and improve retention of a spatial memory task in behaviourally impaired aged rats.

read more

Citations
More filters
Journal ArticleDOI

Experimental approaches and drugs in development for the treatment of dementia.

TL;DR: Treatment of dementia can be divided as symptomatic treatment of cognitive or non-cognitive symptoms and the treatment of underlying pathology, where efforts to treat the underlying pathology are based on modulation of APP processing in order to decrease the accumulation of β-amyloid.
Journal ArticleDOI

Animal models of age- and disease-related cognitive decline: perspectives on the models and therapeutic strategies.

TL;DR: Different aspects of animal models of memory dysfunction will be discussed relative to their ability to assess the structural and functional consequences of central nervous system (CNS) repair.
Journal ArticleDOI

Long-term neuronal effects and disposition of ectopic preproNGF gene transfer into the rat septum.

TL;DR: NGF gene transfer attenuated the lesion-induced loss of septal cholinergic but not GABAergic neurons, indicating that long-term expression did not eliminate this response, which has been noted over short intervals.
Journal ArticleDOI

Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases.

TL;DR: Work that employs viral vector gene therapeutics to modulate the brain’s response to misfolded proteins with a specific focus on neurodegeneration is summarized.
Journal ArticleDOI

Monoamine-activated alpha 2-macroglobulin inhibits choline acetyltransferase of embryonic basal forebrain neurons and reversal of the inhibition by NGF and BDNF but not NT-3.

TL;DR: It is demonstrated that monoamine‐activated α2M is a potent non‐cytotoxic inhibitor of the ChAT activity in cholinergic basal forebrain neurons, and NGF and BDNF are capable of not only stimulating the Chat activity but can also specifically reverse the α2m inhibition.
References
More filters
Journal ArticleDOI

Developments of a water-maze procedure for studying spatial learning in the rat

TL;DR: Developments of an open-field water-maze procedure in which rats learn to escape from opaque water onto a hidden platform are described, suggesting that they may lend themselves to a variety of behavioural investigations, including pharmacological work and studies of cerebral function.
Journal ArticleDOI

The Cholinergic Hypothesis of Geriatric Memory Dysfunction

TL;DR: Biochemical, electrophysiological, and pharmacological evidence supporting a role for cholinergic dysfunction in age-related memory disturbances is critically reviewed and an attempt has been made to identify pseudoissues, resolve certain controversies, and clarify misconceptions that have occurred in the literature.
Journal ArticleDOI

Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

TL;DR: It is suggested that fimbrial transections resulted in retrograde degeneration of cholinergic septo-hippocampal neurons and that NGF treatment strongly attenuated this lesion-induced degeneration.
Journal ArticleDOI

Nerve growth factor treatment after brain injury prevents neuronal death

TL;DR: Cholinergic neuronal degeneration after axotomy has been proposed to be due to the loss of a retrogradely transported neurotrophic factor, possibly nerve growth factor (NGF), and NGF was continuously infused into the lateral ventricles of adult rats that had received bilateral lesions of all cholinergic axons projecting from the medial septum to the dorsal hippocampus.
Related Papers (5)